JP Morgan Private Wealth Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-29,962	Closed	-$19K	–	2020
2022 Q3	$19K	Sell	29,962 -23,165	-44%	-$34.1K	﹤0.01%	1910
2022 Q2	$129K	Sell	53,127 -126,100	-70%	-$350K	﹤0.01%	1861
2022 Q1	$724K	Sell	179,227 -104,290	-37%	-$572K	﹤0.01%	1363
2021 Q4	$2.27M	Buy	283,517 +69,862	+33%	+$819K	﹤0.01%	858
2021 Q3	$4.12M	Buy	213,655 +193,655	+968%	+$3.38M	0.01%	644
2021 Q2	$276K	Buy	+20,000	New	+$237K	﹤0.01%	1700

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SGCA

Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PLXP Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 29,962 shares — an estimated $19K sold.

JP Morgan Private Wealth Advisors first reported a position in PLXP in Q2 2021 and held it in 6 quarters. The position peaked at $4.12M in Q3 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

JP Morgan Private Wealth Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 29,962 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $19K.
JP Morgan Private Wealth Advisors first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and held it in 6 quarters.
JP Morgan Private Wealth Advisors's PLx Pharma Inc. Common Stock position peaked at $4.12M in Q3 2021.
41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.